Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Ethyl Acetate | HCID 8857 | — |
| Reactant | Sodium hydride | HCID 24758 | — |
| Reactant | tert-Butyl bromoacetate | HCID 79177 | — |
| Reactant | HCID 20164896 | HCID 20164896 | — |
| Solvent | Water | HCID 962 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Solvent | Hexamethylphosphoramide | HCID 12679 | — |
| Product | HCID 20164974 | HCID 20164974 | — |
Reaction Steps
To a suspension of 3.4 g of 2-(1-naphthyl)-5-oxo-6-phthalimidoperhydro-1,4-thiazepine [prepared as described in step (e) above] in a mixture of 34 ml of dimethylformamide and 10 ml of hexamethylphosphoric triamide were added dropwise 2.25 ml of t-butyl bromoacetate and then, bit by bit, 609 mg of a 55% w/w suspension of sodium hydride in oil at 0°-5° C., under a nitrogen stream. After this addition, the reaction mixture was stirred for 16 hours at room temperature. Ethyl acetate and water were then added to the reaction mixture. The ethyl acetate layer was separated, washed with water and dried over anhydrous magnesium sulfate, and the solvnet was distilled off. The residue was subjected to silica gel column chromatography using a 2:1 by volume mixture of cyclohexane and ethyl acetate as eluent, to give 2.6 g of the title compound as crystals, melting at 211°-213° C.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US04699905 |
|---|
| Source dataset | uspto-grants-1987_10 |
|---|
| ORD ID | ord-1c76f7cdeb1d4f10bd0141c957fddec4 |
|---|
| Source note | uspto-grants-1987_10 |
|---|